John B Hess bought $2.0M of GS
director at GOLDMAN SACHS GROUP INC. 3,904 shares at an average of $511.68, traded Apr 15, 2025, filed Apr 17, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.0M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +14Price context10% above the 52-week low; 24% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001087997-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +836 | $507.96 | $425k | 836 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +344 | $509.08 | $175k | 1,180 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +353 | $510.23 | $180k | 1,533 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +444 | $511.34 | $227k | 1,977 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +384 | $512.24 | $197k | 2,361 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +393 | $513.22 | $202k | 2,754 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +801 | $514.42 | $412k | 3,555 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +176 | $515.31 | $91k | 3,731 | Apr 17, 2025 |
| Apr 15, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +173 | $517.45 | $90k | 3,904 | Apr 17, 2025 |
| Apr 15, 2025 | AGrant or award Restricted Stock Unitsderivative | +50 | $0.00 | $0 | 383 | Apr 17, 2025 |
Related signals
Other insiders at GOLDMAN SACHS GROUP INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | GSsell GOLDMAN SACHS GROUP INC | Ericka T Leslie Chief Administrative Officer | $620k 600 shares | -5% | |
| 50Moderate | GSsell GOLDMAN SACHS GROUP INC | David M Solomon Chairman of the Board and CEO | $3.0M 5,000 shares | -4% | |
| 50Moderate | GSsell GOLDMAN SACHS GROUP INC | David M Solomon Chairman of the Board and CEO | $1.5M 2,415 shares | -2% | |
| 75Notable | GOLDMAN SACHS GROUP INC | Alex S Golten CHIEF RISK OFFICER | $3.3M 5,208 shares | -59% | |
| 72Notable | GOLDMAN SACHS GROUP INC | Carey Halio Global Treasurer | $2.3M 3,640 shares | -44% | |
| 60Notable | GOLDMAN SACHS GROUP INC | Sheara J Fredman Chief Accounting Officer | $1.3M 2,034 shares | -24% | |
| 50Moderate | GOLDMAN SACHS GROUP INC | Kathryn H. Ruemmler Chief Legal Officer, GC | $4.8M 7,498 shares | -44% | |
| 52Moderate | GOLDMAN SACHS GROUP INC | Carey Halio Global Treasurer | $965k 1,545 shares | -16% | |
| 48Moderate | GSbuy GOLDMAN SACHS GROUP INC | Kevin R Johnson director | $1.5M 2,400 shares | - | |
| 48Moderate | GOLDMAN SACHS GROUP INC | David A Viniar director | $3.1M 5,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.